A team of researchers from the universities of Brighton and Strathclyde has presented a 3D-printed electrochemical sensor capable of detecting a key heart attack biomarker. The device, with a manufacturing cost of just 17 euro cents, identifies cardiac troponin I in blood serum with exceptional clinical sensitivity. This innovation promises to drastically streamline emergency diagnosis, offering a fast and low-cost alternative to current hospital methods.
Additive manufacturing and carbon nanotubes for maximum sensitivity 🔬
The core of the platform consists of electrodes approximately 0.1 mm in size, manufactured with a conventional 3D printer. These electrodes are combined with carbon nanotubes to create a highly effective detection surface. The key innovation lies in avoiding direct chemical modification of the electrode. Instead, the system uses standard lab plates where the detection reaction takes place, improving consistency and facilitating reproducibility. This setup achieved detection of troponin I concentrations of 7.4 pg/mL in undiluted serum, a sensitivity far superior to previous electrochemical methods.
Impact on biomedicine and the future of diagnosis 💡
This technology demonstrates the potential of additive manufacturing to democratize critical diagnostic tools. By reducing cost and complexity, it could be implemented in point-of-care settings, shortening diagnosis time and improving patient outcomes. The work sets a precedent for the development of 3D-printed sensors for other biomarkers, expanding the horizon of personalized and accessible biomedicine.
How can low-cost 3D-printed electrochemical sensors democratize the early diagnosis of cardiovascular diseases?
(P.S.: and if the printed organ doesn't beat, you can always add a little motor... just kidding!)